RT Book, Section
A1 Concus, Adriane P.
A1 Tran, Theresa N.
A1 Sanfilippo, Nicholas J.
A1 DeLacure, Mark D.
A2 Lalwani, Anil K.
SR Print(0)
ID 55768691
T1 Chapter 31. Malignant Laryngeal Lesions
T2 CURRENT Diagnosis & Treatment in Otolaryngology—Head & Neck Surgery, 3e
YR 2012
FD 2012
PB The McGraw-Hill Companies
PP New York, NY
SN 978-0-07-162439-8
LK accesssurgery.mhmedical.com/content.aspx?aid=55768691
RD 2024/04/23
AB Each  year,  11,000  new  cases  of  larynx  cancer  will  be  diagnosed  in  the  United  States  (1%  of  new  cancer  diagnoses),  and  approximately  one-third  of  these  patients  will  die  of  their  disease.  The  current  male-to-female  ratio  for  larynx  cancer  is  4:1,  but  the  relative  percentage  of  women  with  this,  as  with  other  smoking-related  illness,  has  been  on  the  rise.  Larynx  cancer  is  most  prevalent  in  the  sixth  and  seventh  decades  of  life  and  is  more  prevalent  among  lower  socioeconomic  groups,  for  whom  it  is  often  not  diagnosed  until  more  advanced  stages.  More  than  90%  of  larynx  cancer  is  squamous  cell  carcinoma  (SCC)  and  is  directly  linked  to  tobacco  and  excessive  alcohol  use.  Because  of  the  complex  and  multifaceted  nature  of  this  disease,  treatment  planning  is  best  delivered  through  a  multidisciplinary  tumor  board  format.